The University of Chicago Header Logo
Last Name

Sarah Hilkert Rodriguez

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentOphthalmology & Visual Science
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Sarah Rodriguez, MD, MPH, provides comprehensive, compassionate care to children with decreased vision in one or both eyes. Dr. Rodriguez has a special interest in treating conditions caused by abnormal eye development, such as amblyopia (lazy eye), strabismus (misalignment of the eyes), pediatric cataracts, and retinopathy of prematurity. She also specializes in adjustable sutures for adult strabismus surgery.

    Dr. Rodriguez is not only passionate about delivering high-quality care to her patients, but she is also dedicated to resident education and clinical research. Most of her research focuses on retinopathy of prematurity (ROP), and she recently received a grant from the Knights Templar Eye Foundation to study neurodevelopmental outcomes among infants screened for ROP. She is also the principle investigator for the University of Chicago's involvement in PEDIG. Dr. Rodriguez's research has been published in a number of scientific journals, including Ophthalmology, JAAPOS, and Survey of Ophthalmology.

    Having completed several medical mission trips to Ghana and Nicaragua, she also has an interest in health disparities and global health. She recently participated in ROP workshops in Vietnam and South Africa, and she is a committee member for IPOSC ROP Africa.

    Collapse Biography 
    Collapse education and training
    Northwestern Memorial / Lurie Children's Hospital, Chicago, ILFellowship06/2016Pediatric Ophthalmology
    The Ohio State University Havener Eye Institute, Columbus, OHResidency06/2015Ophthalmology
    Scripps Mercy Hospital, San Diego, CAInternship06/2012Transitional Year
    The Ohio State University College of Medicine, Columbus, OHMD06/2011Medicine
    La Cayetana Hereredia, Lima, Peru04/2011Tropical Medicine Course
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MDMPH05/2010Public Health
    University of Notre Dame, Notre Dame, INBA06/2006Phiosophy
    Collapse awards and honors
    2018 - 2019Reviewer, Retina
    2017 - 2019Reviewer, JAAOPS
    2014Havener Eye Institute Free Clinic Certificate of Appreciation, Ohio State Havener Eye Institute
    2014Travel Grant Award for ARVO, National Eye Institute
    2013Consultant of the Month, Ohio State Havener Eye Institute
    2012Mercy Style of Care Award, Scripps Mercy Hospital
    2011Eli G. Alcon Award for Outstanding Senior Medical Student in Ophthalmology, The Ohio State University College of Medicine
    2010Capstone Award for Outstanding Achievement , Johns Hopkins Bloomberg School of Public Health
    2010Health Economics Certificate, Johns Hopkins Bloomberg School of Public Health
    2010AOA, The Ohio State University, College of Medicine
    2009Gold Humanism and Honor Society, The Ohio State University, College of Medicine

    Collapse ORNG Applications 
    Collapse Twitter
    Collapse Websites

    Collapse Research 
    Collapse research activities and funding
         (Hilkert Rodriguez, Sarah)Jan 1, 2016 - Jun 30, 2017
    Rainbow Study
    Role Description: a randomized, controlled study evaluating the efficacy and safety of ranibizumab compared with laser therapy for the treatment of infants born prematurely with retinopathy of prematurity.
    Role: PI

         (Zhang, Michael)May 1, 2017 - Jun 30, 2017

    Diversity Grant: Assessing Socioeconomic Status as a Risk Factor for Severe Retinopathy of Prematurity
    Role: Mentor for medical student, Michael Zhang

         (Anand, Nandita)Jun 1, 2017 - Jun 1, 2018

    Role Description: ISPB Research Grant: To evaluate the long term safety and efficacy of antivascular endothelial growth factor (anti-VEGF) treatment compared to laser among patients who received treatment for retinopathy of prematurity.
    Role: Mentor of ophthalmology resident

         (Hilkert Rodriguez, Sarah)Aug 1, 2017 - Aug 1, 2018

    Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity.
    Role: PI

         (Hilkert Rodriguez, Sarah)Jan 1, 2018

    Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity
    Role: PI

         (Theophanous, Christos)Jun 1, 2018

    ISPB Research Grant: Proteomics in pediatric cataracts.
    Role: Mentor for ophthalmology resident, Christos Theophanous

         (Hilkert-Rodriguez, Sarah)Jun 1, 2018 - Jun 1, 2019
    Knights Templar
    Evaluating the efficacy of a smartphone application (Baby Moves!) to detect developmental delays among a high risk population of infants screened for retinopathy of prematurity.
    Role: PI

         (Hilkert-Rodriguez, Sarah)Oct 1, 2018

    ROP Hot Topics
    Role Description: Co-organizer for international ROP meeting, raised funding from sponsors for meeting support
    Role: Co-organizer

         (Elise Timtim)Jun 1, 2019 - Jun 30, 2020
    ROP Outcomes using the Medicaid Claims Database
    Role: Mentor for medical student, Elise Timtim

         (Elise Timtim)Jun 1, 2019 - Jun 30, 2020
    AOA Carolyn L. Kuckein Student Research Fellowship
    ROP Outcomes using the Medicaid Claims Database
    Role: Mentor for medical student, Elise Timtim

         (Hilkert Rodriguez, Sarah)Jun 25, 2019

    Role: PI for the University of Chicago

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rodriguez SH, Peyton C, Lewis K, Andrews B, Greenwald MJ, Schreiber MD, Msall ME, Blair MP. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 Jun 01; 50(6):337-343. PMID: 31233150.
      View in: PubMed
    2. Schechet SA, Rodriguez SH, Shapiro MJ, Blair MP. Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity". Taiwan J Ophthalmol. 2019 Apr-Jun; 9(2):136-137. PMID: 31198676.
      View in: PubMed
    3. Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 Apr; 23(2):88.e1-88.e6. PMID: 30797978.
      View in: PubMed
    4. Theophanous C, Schechet S, Rodriguez SH, Blair M. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896. PMID: 30457649.
      View in: PubMed
    5. Blair M, Gonzalez JMG, Snyder L, Schechet S, Greenwald M, Shapiro M, Rodriguez SH. Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248. PMID: 30637196.
      View in: PubMed
    6. Blair MP, Hilkert Rodriguez S, Chan RVP, Shapiro MJ. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71. PMID: 30243341.
      View in: PubMed
    7. Tina H. Chen, Kathryn A. Colby, Sarah Hilkert Rodriguez, Mark B. Slidell, Jessica J. Kandel, Hassan A. Shah. Availability of Resources for After-Hours Surgical Management of Eye Injuries. J Acad Ophthalm. 2018; 1(10):e92-e97.
    8. Hilkert SM, Parness-Yossifon R, Mets-Halgrimson R, Mets MB. Response to Galvis et al.'s "Myopia rates in a genetically isolated population". Ophthalmic Genet. 2018 04; 39(2):295. PMID: 29172911.
      View in: PubMed
    9. Silas MR, Hilkert SM, Reidy JJ, Farooq AV. Posterior keratoconus. Br J Ophthalmol. 2018 07; 102(7):863-867. PMID: 29122822.
      View in: PubMed
    10. Hilkert SM, Parness-Yossifon R, Mets-Halgrimson R, Mets MB. Ocular biometry and determinants of refractive error in a founder population of European ancestry. Ophthalmic Genet. 2018 Jan-Feb; 39(1):11-16. PMID: 28569566.
      View in: PubMed
    11. Hilkert SM, Farooq AV, Greenwald MJ . Retinoblastoma: a global perspective. Curr Ophthalmol Rep. 2017; (5):119-127.
    12. Hilkert SM, Koreishi AF, Pyatetsky D. Poststreptococcal syndrome presenting as posterior scleritis in a child. J AAPOS. 2017 Apr; 21(2):163-165. PMID: 28007653.
      View in: PubMed
    13. Hilkert SM, Cebulla CM, Jain SG, Pfeil SA, Benes SC, Robbins SL. Breaking bad news: A communication competency for ophthalmology training programs. Surv Ophthalmol. 2016 Nov - Dec; 61(6):791-798. PMID: 27134009.
      View in: PubMed
    14. DiVittorio KM, Leevy WM, O'Neil EJ, Johnson JR, Vakulenko S, Morris JD, Rosek KD, Serazin N, Hilkert S, Hurley S, Marquez M, Smith BD. Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics. Chembiochem. 2008 Jan 25; 9(2):286-93. PMID: 18076009.
      View in: PubMed
    Hilkert Rodriguez's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description